The role of moclobemide in endogenous depression: a survey of recent data

  title={The role of moclobemide in endogenous depression: a survey of recent data},
  author={B. Woggon},
  journal={International Clinical Psychopharmacology},
  • B. Woggon
  • Published 1993
  • Psychology, Medicine
  • International Clinical Psychopharmacology
Earlier studies demonstrated that moclobemide has good efficacy as an antidepressant. Its efficacy was comparable to reference antidepressants, both in endogenous and non-endogenous depression. A meta-analysis was performed of recent data from more than 2000 patients who had participated in double-blind trials with moclobemide and comparison drugs. Based on HAMD-17 baseline scores, the sample was divided into three groups according to the severity of depression. In all three, moclobemide was as… Expand
6 Citations
A Risk-Benefit Assessment of Moclobemide in the Treatment of Depressive Disorders
SummaryMoclobemide, a novel benzamide, is a reversible inhibitor of monoamine oxidase-A (RIMA). It has been extensively evaluated in the treatment of a wide spectrum of depressive disorders.Expand
Clinical efficacy of reversible and selective inhibitors of monoamine oxidase A in major depression
  • E. Paykel
  • Psychology, Medicine
  • Acta psychiatrica Scandinavica. Supplementum
  • 1995
The evidence indicates that moclobemide is effective in typical severe depression with melancholia rather than being limited to less lypical subtypes. Expand
Recent developments in antidepressants
Clinical experience to date with tricyclic and monoamine oxidase A selective, rapidly reversible MAOIs suggests that their effects are not limited to atypical depression, but extend across the range of depressive disorders. Expand
A 47-year-old man with chronic depression.
A 47-year-old man who has struggled with depression for approximately 15 years is a father of two teenaged children who works for a local human service institution and receives private managed health insurance through his employer. Expand
Assessing the quality of reports of randomised trials: implications for the conduct of meta-analyses.
This work aims to provide a database of systematic reviews of systematic Reviews of Pediatrics and Biostatistics for use in clinical practice and aims to rank the reviews according to their quality and adequacy. Expand